Key Points
- Director Julie Cullivan sold 9,122 shares on March 5 at an average of $25.00 for proceeds of $228,050, trimming her position by 25.05% to 27,291 shares (≈$682,275).
- Stock snapshot: HTFL opened at $22.98, trades below its 50- and 200-day moving averages ($28.43 and $30.96), has a one-year range of $20.13–$41.22, a market cap of $1.96B and a negative PE of -12.70.
- Analyst consensus is moderately positive: five Buys, two Holds and one Sell yield an average "Moderate Buy" rating and an average target price of $38.50.
Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) Director Julie Cullivan sold 9,122 shares of the firm's stock in a transaction that occurred on Thursday, March 5th. The shares were sold at an average price of $25.00, for a total transaction of $228,050.00. Following the transaction, the director directly owned 27,291 shares in the company, valued at approximately $682,275. The trade was a 25.05% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.
Heartflow Price Performance
Shares of HTFL opened at $22.98 on Friday. The company's fifty day moving average price is $28.43 and its 200 day moving average price is $30.96. Heartflow, Inc. has a one year low of $20.13 and a one year high of $41.22. The company has a market capitalization of $1.96 billion and a PE ratio of -12.70.
Institutional Trading of Heartflow
Large investors have recently modified their holdings of the stock. Caitong International Asset Management Co. Ltd purchased a new position in shares of Heartflow in the 4th quarter worth about $27,000. TFC Financial Management Inc. purchased a new position in Heartflow in the 3rd quarter worth approximately $40,000. Russell Investments Group Ltd. purchased a new stake in shares of Heartflow during the 4th quarter valued at $45,000. Legal & General Group Plc purchased a new position in Heartflow in the third quarter worth $59,000. Finally, Strs Ohio purchased a new stake in Heartflow during the fourth quarter valued at about $99,000.
Wall Street Analysts Forecast Growth
HTFL has been the subject of a number of recent analyst reports. Canaccord Genuity Group upped their price objective on Heartflow from $39.00 to $40.00 and gave the company a "buy" rating in a report on Thursday, November 13th. Wells Fargo & Company began coverage on shares of Heartflow in a research report on Wednesday, January 28th. They issued an "overweight" rating and a $38.00 price target on the stock. JPMorgan Chase & Co. upped their target price on shares of Heartflow from $36.00 to $40.00 and gave the company an "overweight" rating in a research note on Thursday, November 13th. Weiss Ratings reissued a "sell (d)" rating on shares of Heartflow in a research report on Monday, December 29th. Finally, Stifel Nicolaus increased their price target on Heartflow from $35.00 to $40.00 and gave the company a "buy" rating in a research report on Thursday, November 13th. Five analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $38.50.
Get Our Latest Stock Analysis on Heartflow
About Heartflow
(
Get Free Report)
HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company's core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow's analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.
HeartFlow's cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
